Related Experiment Videos
Serial evaluation of lymphocyte function in bone marrow-grafted patients.
Diagnostic Immunology
|January 1, 1986
Summary
Bone marrow transplant recipients show immune deficiencies, increasing infection risk. Cellular and humoral immunity, including gamma interferon and interleukin-2 production, gradually recover within a year post-transplant.
Area of Science:
- Immunology
- Transplantation Medicine
- Cellular Biology
Background:
- Bone marrow transplantation (BMT) is crucial for treating hematologic malignancies but leads to immune deficiencies.
- These deficiencies increase the risk of severe infections in transplant recipients.
- Understanding immune reconstitution post-BMT is vital for improving patient outcomes.
Purpose of the Study:
- To evaluate the recovery of cellular immunity in bone marrow transplant recipients.
- To assess the production of key lymphokines, gamma interferon (IFN-γ) and interleukin-2 (IL-2), post-BMT.
- To investigate the impact of graft-versus-host disease (GVHD) on immune recovery.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) were collected from nine BMT patients at 3-month intervals during the first year.
- PBMC proliferation was measured via phytohemagglutinin (PHA)-stimulated lymphocyte blastogenesis.
- Lymphokine production (IFN-γ and IL-2) was assessed in cell culture supernatants.
Main Results:
- Lymphocyte blastogenesis normalized within 3-6 months post-BMT.
- IFN-γ and IL-2 production remained lower than normal in patients within the first year.
- Two patients with acute GVHD exhibited persistently impaired immune responses at 12 months.
Conclusions:
- Immune recovery, particularly lymphokine production, is delayed post-BMT.
- Graft-versus-host disease significantly hinders immune reconstitution.
- Further strategies are needed to enhance immune recovery and reduce infection risk after BMT.